Search Results for "Pharmacovigilance Conference"

09:50 EDT 26th May 2015 | BioPortfolio

Matching Channels

BioPortfolio - life science, medical devices and pharmaceutical conference

BioPortfolio is an internet agent for Visiongain's life science, medical devices and pharmaceutical conference.

Management Forum - highest quality conference, seminar and knowledge-based experiences

Since 1983, Management Forum have built a reputation on providing the highest quality conference, seminar and knowledge-based experiences for leading professionals in some of the world's most...

Matching News

Essjay Solutions Presenting at 4th Annual Pharmacovigilance Conference in Dubai

London, United Kingdom, December 04, 2014 --(PR.com)-- Dr Seema Jaitly, Founder of Essjay Solutions, was invited to present due to her extensive knowledge in the pharmacovigilance space and will be p...

Pharmacovigilance Inspections: Trends and Tools.

At the 2014 World Drug Safety Congress Americas, Daniel Tripp, Pfizer, gave a presentation on “Pharmacovigilance Inspections: Trends and Tools.” Download and learn: Pharmacovigilance Inspe...

Whitepaper: Proactive Pharmacovigilance

White paper provided by Sciformix. Click here for more information  21st century technologies will create significant opportunities and challenges for all health care stakeholders. Pharmacovigilance...

Whitepaper: Sponsor & CRO Pharmacovigilance Alliances

Outsourcing pharmacovigilance activities is a standard business practice in a rapidly expanding market segment. In the past, outsourced safety services were limited due to concerns about confidentia...

8th Pharmacovigilance 2015 24th & 25th February 2015, Marriott Marble Arch Hotel, London, UK

8th Annual Pharmacovigilance 2015 will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.  The entire pro...

Whitepaper: A successful path to fulfilling pharmacovigilance obligations

White paper provided by Sciformix. Click here for more information  As the number of innovator pharmaceutical and generic manufacturer partnerships grow, the lines of responsibility for meeting ph...

Vigilance in Pharmacovigilance: Human Factors and Attention

At the 2014 Drug Safety Congress Europe event, Alan Hochberg, F Hoffmann La-Roche AG, gave the presentation “Vigilance in Pharmacovigilance: Human Factors and Attention.” Download ... The ...

News and press releases: Regulatory information – EMA provides advice notes on pharmacovigilance annual fees

Marketing-authorisation holders are advised to liaise with their qualified persons for pharmacovigilance prior to invoicing in July 2015

Matching PubMed Articles

A Review of Pharmacovigilance.

Pharmacovigilance supports safe and appropriate use of drugs. Spontaneous reporting of adverse drug reactions (ADRs) is an essential component of pharmacovigilance. However, there is significant under...

Effect of educational intervention on adverse drug reporting by physicians: a cross-sectional study.

In India, the pharmacovigilance program is still in its infancy. National Pharmacovigilance Program of India was started for facilitating the pharmacovigilance activities. The ADR reporting rate is st...

A Description of Signals During the First 18 Months of the EMA Pharmacovigilance Risk Assessment Committee.

New pharmacovigilance legislation in the European Union has underlined the importance of signal management, giving the European Medicines Agency's newly established Pharmacovigilance Risk Assessment C...

Pharmacovigilance Discussion Forum - The European Generic Medicines Association's 8th Annual Meeting (January 21, 2015 - London, UK).

The practice and science of pharmacovigilance first emerged following the disaster caused by thalidomide in 1961, which led to the initiation of systemic international efforts to address drug safety i...

Risk management plans as tool for proactive pharmacovigilance: a cohort study of newly approved drugs in Europe.

Risk Management Plans (RMPs) have become a cornerstone in pharmacovigilance of new drugs in Europe. The RMP was introduced in 2005 to support a proactive approach in gaining knowledge on safety concer...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement